openPR Logo
Press release

Deadline in Lawsuit coming up on July 27th for Investors in Sorrento Therapeutics, Inc. (NASDAQ: SRNE)

07-15-2020 05:33 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on July 27, 2020 in the lawsuit for certain investors in Sorrento Therapeutics, Inc. (NASDAQ: SRNE).

A Deadline is coming up on July 27, 2020 in the lawsuit for certain investors in Sorrento Therapeutics, Inc. (NASDAQ: SRNE).

The Shareholders Foundation announced that a deadline is coming up on July 27, 2020 in the lawsuit filed for certain investors of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) over alleged securities laws violations by Sorrento Therapeutics, Inc.

Investors who purchased shares of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) have certain options and there are strict and short deadlines running. Deadline: July 27, 2020. NASDAQ: SRNE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges on behalf of purchasers of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) common shares between May 15, 2020 and May 22, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 15, 2020 and May 22, 2020, Sorrento Therapeutics, Inc. failed to disclose that the Company’s initial finding of “100% inhibition” in an in vitro virus infection will not necessarily translate to success or safety in vivo, or in person, that the Company’s finding was not a “cure” for COVID-19; and (ii) as a result of the foregoing, the lawsuit alleges that Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis in violation of section 10(b) of the Securities Exchange Act of 1934.

Those who purchased shares of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline in Lawsuit coming up on July 27th for Investors in Sorrento Therapeutics, Inc. (NASDAQ: SRNE) here

News-ID: 2090780 • Views: 1446

More Releases from Shareholders Foundation

Investigation announced for Long-Term Investors in shares of Fifth Third Bancorp …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Fifth Third Bancorp. Investors who purchased shares of Fifth Third Bancorp (NASDAQ: FITB) and currently hold any of those Fifth Third Bancorp (NASDAQ: FITB shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Fifth Third Bancorp (NASDAQ: FITB
Investigation announced for Long-Term Investors in shares of HF Foods Group Inc. …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of HF Foods Group Inc.. Investors who are current long term investors in HF Foods Group Inc. (NASDAQ: HFFG) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: HFFG stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in shares of InnerWorkings, Inc. …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at InnerWorkings, Inc. Investors who purchased shares of InnerWorkings, Inc. (NASDAQ: INWK) and currently hold any of those NASDAQ: INWK shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain InnerWorkings directors breached their fiduciary duties and caused damage to
Lawsuit filed for Investors in shares of Guidewire Software, Inc. (NYSE: GWRE)
An investor, who purchased shares of Guidewire Software, Inc. (NYSE: GWRE), filed a lawsuit over alleged Securities Laws violations by Guidewire Software, Inc. Investors who purchased shares of Guidewire Software, Inc. (NYSE: GWRE) have certain options and for certain investors are short and strict deadlines running. Deadline: September 23, 2020. NYSE: GWRE investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. San Mateo, CA based Guidewire Software,

All 5 Releases


More Releases for Sorrento

Top Key Players Operating in the Global NK Cells Market are Altor Bioscience Cor …
The global natural killer (NK) cell therapeutics market is expected to witness considerable growth due to increasing awareness regarding immunotherapy, advancement in technologies, high demand for safe and effective medication, reduction of side effects, high prevalence of chronic diseases such as cancer and cardiovascular diseases, and increasing incidences of infectious diseases. The regulatory bodies are supporting the growth of the global market by providing funding, designations and grants for speeding
Myc Proto Oncogene Protein Market Research Report 2019-2025 | Top Key Players …
UpMarketResearch offers a latest published report on “Global Myc Proto Oncogene Protein Market Analysis and Forecast 2019-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 119 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/49989 Myc Proto Oncogene Protein Market research report
Natural Killer Cells Market Driver, Trends, Applications & Business Strategy By …
Studies have also been carried to express the vitality of natural killer cells’ response against infected cells by various intracellular bacteria such as Listeria, Salmonella and Legionella in humans. Recent advancements have proven the exclusive role of killer cells in the innate immune response to microbial pathogens. Killer cell also work through another approach of direct recognition of pathogen derived structures on the surface of the infected cell. The immediate
Natural Killer Cells Market 2026: Revenue And Growth Analysis By Top Players Nan …
Natural killer cells are a form of granular lymphocytes of varying sizes that play an important role in innate immunity in the human body. They typically constitute of around 10% of total blood lymphocytes as compared to around 70% and 20% of T cells and B cells, respectively. Natural killer cells are cytotoxic in nature and are able to kill their targets cells by two different mechanisms: as antibody dependent
Natural Killer Cells Market Insights With Key Players NantKwest, NKT Therapeutic …
Natural killer cells are a form of granular lymphocytes of varying sizes that play an important role in innate immunity in the human body. They typically constitute of around 10% of total blood lymphocytes as compared to around 70% and 20% of T cells and B cells, respectively. Natural killer cells are cytotoxic in nature and are able to kill their targets cells by two different mechanisms: as antibody dependent
CAR T Cell Therapy Market | Growing Industry Crucial Key Players - Novartis Inte …
CAR T Cell Therapy Market Potential: A Significant Scope for the Treatment of Blood Cancer The report " CAR T Cell Therapy Market [By Target Antigen (CD19, CD20, MESO, HER2, EGFRV III, and Others); By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, and Others); and By Regions]: Market size & Forecast, 2018 – 2025." The global CAR T Cell Therapy market is anticipated to